Directory
>
Doug Burdette
Doug Burdette
Vice President of DMPK | Frontier Medicines
Waltham, Massachusetts, United States
Doug Burdette
Summary
Doug Burdette is an accomplished professional in the biopharmaceutical sector, currently serving as the Vice President of DMPK at Frontier Medicines and previously as the Director of DMPK and Clinical Pharmacology at Moderna Therapeutics. With a strong academic foundation in biochemistry, Doug has amassed over two decades of experience in drug metabolism, pharmacokinetics, and clinical development. His expertise spans various therapeutic areas, including neurology and oncology, where he has led teams in drug discovery and development. Doug has a proven track record of working with leading organizations such as Biogen, Novartis, and AstraZeneca, contributing significantly to the advancement of pharmaceutical research. His leadership style emphasizes collaboration and innovation, driving teams toward achieving strategic goals. Doug's passion for science is matched by his commitment to mentoring the next generation of scientists in the field. He holds a PhD from Michigan State University and has completed postdoctoral studies at the University of California, Berkeley.
Doug Burdette
Work Experience
Vice President of DMPK at
Frontier Medicines
July 2023 - Present
Director at
Moderna Therapeutics
October 2019 - August 2023
Director, DMPK at
Biogen
September 2017 - October 2019
Neuroscience, Cardiovascular, and Metabolic Disease Area Drug Metabolism and Pharmacokinetic Lead at
Novartis
January 2014 - August 2017
Director, Global Project Leader at
AstraZeneca
January 2012 - January 2014
Assoc. Director at
AstraZeneca
January 2007 - January 2012
PDM Scientist at
Pfizer, Inc.
January 2000 - January 2007
HTS scientist at
Pfizer, Inc.
January 2000 - January 2003
Student Intern at
Parke Davis
January 1993 - January 1994
Doug Burdette
Education
Univ. California, Berkeley, Post Doctoral Study
January 1996 - January 1998
Michigan State University, Phd
January 1992 - January 1996
University of Michigan, Bs Biology
January 1982 - January 1987
Frequently Asked Questions about Doug Burdette
What is Doug Burdette email address?
Doug Burdette's primary email address is *********@frontiermeds.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Doug Burdette work for?
Doug Burdette is a Vice President of DMPK at Frontier Medicines, a company specializing in Commercial physical research.
Where Doug Burdette graduated from?
Doug Burdette holds a degree in Biochemistry from Univ. California, Berkeley.
How can I directly contact Doug Burdette?
To contact Doug Burdette directly, you can use the email address *********@frontiermeds.com. Complete contact information is available upon registration with Muraena.
Who is Doug Burdette?
Doug Burdette is an accomplished professional in the biopharmaceutical sector, currently serving as the Vice President of DMPK at Frontier Medicines and previously as the Director of DMPK and Clinical Pharmacology at Moderna Therapeutics. With a strong academic foundation in biochemistry, Doug has amassed over two decades of experience in drug metabolism, pharmacokinetics, and clinical development. His expertise spans various therapeutic areas, including neurology and oncology, where he has led teams in drug discovery and development. Doug has a proven track record of working with leading organizations such as Biogen, Novartis, and AstraZeneca, contributing significantly to the advancement of pharmaceutical research. His leadership style emphasizes collaboration and innovation, driving teams toward achieving strategic goals. Doug's passion for science is matched by his commitment to mentoring the next generation of scientists in the field. He holds a PhD from Michigan State University and has completed postdoctoral studies at the University of California, Berkeley.
Doug`s contact details
*********@frontiermeds.com
Colleagues
VP, Information Technology
Vice President, Head of Chemistry
Chief Of Staff
Co-director, Molecular Therapeutics Initiative
Chief Innovation Officer
Co-Founder
Vice President Finance
Chief Science Officer
Chief Technology Officer
Senior Vice President, Strategy and Corporate Affairs